Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.41) per share. This is a 17.14 percent decrease over losses of $(0.35) per share from the same period last year.
GreenLight Biosciences Announces Expiration Of Tender Offer Period For Outstanding Shares
GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA) ("GreenLight" or the "Company") today announced that it is initiating the final steps in closing its previously announced merger with SW MergerCo,
